{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T20:43:49Z","timestamp":1770324229337,"version":"3.49.0"},"reference-count":21,"publisher":"Aging and Disease","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging and disease"],"published-print":{"date-parts":[[2015]]},"DOI":"10.14336\/ad.2014.0925","type":"journal-article","created":{"date-parts":[[2015,6,6]],"date-time":"2015-06-06T03:42:12Z","timestamp":1433562132000},"page":"168","source":"Crossref","is-referenced-by-count":15,"title":["Plasma Epidermal Growth Factor Decreased in the Early Stage of Parkinson\u2019s Disease"],"prefix":"10.14336","volume":"6","author":[{"given":"Qian-Wen","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miao-Miao","family":"Hou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-Dong","family":"Tang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Wen","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Fang","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng-Di","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"5462","reference":[{"key":"key-10.14336\/AD.2014.0925-1","doi-asserted-by":"crossref","unstructured":"Lees AJ, Hardy J, Revesz T(2009). Parkinson's disease. Lancet, 373(9680):2055-2066.","DOI":"10.1016\/S0140-6736(09)60492-X"},{"key":"key-10.14336\/AD.2014.0925-2","doi-asserted-by":"crossref","unstructured":"Weissmiller AM, Wu C (2012). Current advances in using neurotrophic factors to treat neurodegenerative disorders. Translational neurodegeneration, 1(1):14.","DOI":"10.1186\/2047-9158-1-14"},{"key":"key-10.14336\/AD.2014.0925-3","doi-asserted-by":"crossref","unstructured":"Allen SJ, Watson JJ, Shoemark DK, Barua NU, Patel NK (2013). GDNF, NGF and BDNF as therapeutic options for neurodegeneration. Pharmacology & therapeutics, 138(2):155-175.","DOI":"10.1016\/j.pharmthera.2013.01.004"},{"key":"key-10.14336\/AD.2014.0925-4","doi-asserted-by":"crossref","unstructured":"Gomez-Pinilla F, Knauer DJ, Nieto-Sampedro M (1998). Epidermal growth factor receptor immunoreactivity in rat brain. Development and cellular localization. Brain research, 438(1-2):385-390.","DOI":"10.1016\/0006-8993(88)91369-8"},{"key":"key-10.14336\/AD.2014.0925-5","doi-asserted-by":"crossref","unstructured":"Iwakura Y, Piao YS, Mizuno M, et al (2005). Influences of dopaminergic lesion on epidermal growth factor-ErbB signals in Parkinson's disease and its model: neurotrophic implication in nigrostriatal neurons. Journal of neurochemistry, 93(4):974-983.","DOI":"10.1111\/j.1471-4159.2005.03073.x"},{"key":"key-10.14336\/AD.2014.0925-6","doi-asserted-by":"crossref","unstructured":"Grainne C.O Keeffe, Pam Tyers, Dag Aarslandet al (2009). Dopamine-induced proliferation of adult neural precursor cells in the mammalian subventricular zone is mediated through EGF. PNAS, 106: 8754-8759","DOI":"10.1073\/pnas.0803955106"},{"key":"key-10.14336\/AD.2014.0925-7","doi-asserted-by":"crossref","unstructured":"Pezzoli G, Zecchinelli A, Ricciardi S, et al (1991). Intraventricular infusion of epidermal growth factor restores dopaminergic pathway in hemiparkinsonian rats. Movement disorders: official journal of the Movement Disorder Society, 6(4):281-287.","DOI":"10.1002\/mds.870060403"},{"key":"key-10.14336\/AD.2014.0925-8","doi-asserted-by":"crossref","unstructured":"Chen-Plotkin AS, Hu WT, Siderowf A, et al (2011). Plasma epidermal growth factor levels predict cognitive decline in Parkinson disease. Annals of neurology, 69(4):655-663.","DOI":"10.1002\/ana.22271"},{"key":"key-10.14336\/AD.2014.0925-9","doi-asserted-by":"crossref","unstructured":"Kuhlenb\u00e4umer G, Hopfner F, Deuschl G (2014).Genetics of essential tremor: meta-analysis and review.Neurology, 82(11):1000-7.","DOI":"10.1212\/WNL.0000000000000211"},{"key":"key-10.14336\/AD.2014.0925-10","doi-asserted-by":"crossref","unstructured":"Delay C, Tremblay C, Brochu E, et al (2014).Increased LINGO1 in the cerebellum of essential tremor patients.Mov Disord. Feb 14. [Epub ahead of print]","DOI":"10.1002\/mds.25819"},{"key":"key-10.14336\/AD.2014.0925-11","doi-asserted-by":"crossref","unstructured":"Inoue H, Lin L, Lee X, et al (2007). Inhibition of the leucine-rich repeat protein LINGO-1 enhances survival, structure, and function of dopaminergic neurons in Parkinson's disease models.PNAS, 104(36):14430-14435.","DOI":"10.1073\/pnas.0700901104"},{"key":"key-10.14336\/AD.2014.0925-12","doi-asserted-by":"crossref","unstructured":"Deuschl G, Bain P, Brin M (1998). Consensus statement of the Movement Disorder Society on Tremor. Ad Hoc Scientific Committee. Movement disorders: official journal of the Movement Disorder Society, 13 Suppl 3:2-23.","DOI":"10.1002\/mds.870131303"},{"key":"key-10.14336\/AD.2014.0925-13","doi-asserted-by":"crossref","unstructured":"Chen W, Chen S, Kang WY, et al (2012). Application of odor identification test in Parkinson's disease in China: a matched case-control study. Journal of the neurological sciences, 316(1-2):47-50.","DOI":"10.1016\/j.jns.2012.01.033"},{"key":"key-10.14336\/AD.2014.0925-14","doi-asserted-by":"crossref","unstructured":"Booij J, Tissingh G, Boer GJ, et al (1997). [123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease. Journal of neurology, neurosurgery, and psychiatry, 62(2):133-140.","DOI":"10.1136\/jnnp.62.2.133"},{"key":"key-10.14336\/AD.2014.0925-15","unstructured":"Brusa L, Pavino V, Massimetti MC, Bove R, Iani C, Stanzione P (2013). The effect of dopamine agonists on cognitive functions in non-demented early-mild Parkinson's disease patients. Functional neurology, 28(1):13-17."},{"key":"key-10.14336\/AD.2014.0925-16","doi-asserted-by":"crossref","unstructured":"Babij R, Lee M, Cortes E, Vonsattel JP, Faust PL, Louis ED (2013). Purkinje cell axonal anatomy: quantifying morphometric changes in essential tremor versus control brains. Brain: a journal of neurology, 136(Pt 10):3051-3061.","DOI":"10.1093\/brain\/awt238"},{"key":"key-10.14336\/AD.2014.0925-17","doi-asserted-by":"crossref","unstructured":"Birecree E, King LE, Jr., Nanney LB (1991). Epidermal growth factor and its receptor in the developing human nervous system. Brain research Developmental brain research, 60(2):145-154.","DOI":"10.1016\/0165-3806(91)90043-I"},{"key":"key-10.14336\/AD.2014.0925-18","doi-asserted-by":"crossref","unstructured":"Kuo SH, Tang G, Louis ED, et al (2013). Lingo-1 expression is increased in essential tremor cerebellum and is present in the basket cell pinceau. Acta neuropathologica, 125(6):879-889.","DOI":"10.1007\/s00401-013-1108-7"},{"key":"key-10.14336\/AD.2014.0925-19","doi-asserted-by":"crossref","unstructured":"Zhou ZD, Sathiyamoorthy S, Tan EK (2012). LINGO-1 and Neurodegeneration: Pathophysiologic Clues for Essential Tremor. Tremor and other hyperkinetic movements, 2.pii: tre-02-51-249-1.","DOI":"10.5334\/tohm.111"},{"key":"key-10.14336\/AD.2014.0925-20","doi-asserted-by":"crossref","unstructured":"Pellecchia MT, Santangelo G, Picillo M, et al (2013). Serum epidermal growth factor predicts cognitive functions in early, drug-naive Parkinson's disease patients. Journal of neurology, 260(2):438-444.","DOI":"10.1007\/s00415-012-6648-6"},{"key":"key-10.14336\/AD.2014.0925-21","doi-asserted-by":"crossref","unstructured":"Rocha NP, Teixeira AL, Scalzo PL, et al (2014). Plasma levels of soluble tumor necrosis factor receptors are associated with cognitive performance in Parkinson's disease. Movement disorders: official journal of the Movement Disorder Society, 29(4):527-31.","DOI":"10.1002\/mds.25752"}],"container-title":["Aging and disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.aginganddisease.org\/fileup\/2152-5250\/PDF\/2152-5250-2015-3-168.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,31]],"date-time":"2021-07-31T23:15:35Z","timestamp":1627773335000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.aginganddisease.org\/EN\/10.14336\/AD.2014.0925"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.14336\/ad.2014.0925","relation":{},"ISSN":["2152-5250"],"issn-type":[{"value":"2152-5250","type":"print"}],"subject":[],"published":{"date-parts":[[2015]]}}}